Synageva BioPharma Raises $30 Million
Synageva BioPharma Corp., a Waltham, Mass.-based developer of protein therapeutics, has held a $30 million first close on its sixth funding round. Baker Brothers Investments led the tranche, and was joined by Tullis Dickerson and Four Partners. The company previously raised over $50 million.
15 April 2009•3 mins read
